The high frequency of anti-PF4/heparin antibodies in patients with COVID-19 is neither related to heparin treatment or to an increased incidence of thrombosisTiffany Pascreau, Marc Vasse, Patrick Van Dreden et al.|Clinical Chemistry and Laboratory Medicine (CCLM)|2021Cited by 12